Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer

SIMPLE SUMMARY: Pathological complete response (pCR) after neoadjuvant chemotherapy can predict survival outcomes in patients with early triple negative breast cancer (TNBC). The immune microenvironment can affect response to chemotherapy. We combined several immune-related biomarkers (TILs, PD-L1 a...

詳細記述

保存先:
書誌詳細
出版年:Cancers (Basel)
主要な著者: Cerbelli, Bruna, Scagnoli, Simone, Mezi, Silvia, De Luca, Alessandro, Pisegna, Simona, Amabile, Maria Ida, Roberto, Michela, Fortunato, Lucio, Costarelli, Leopoldo, Pernazza, Angelina, Strigari, Lidia, Della Rocca, Carlo, Marchetti, Paolo, d’Amati, Giulia, Botticelli, Andrea
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565153/
https://ncbi.nlm.nih.gov/pubmed/32947953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092648
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料